Home » Topics » BioWorld Science

BioWorld Science
RSS

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

BB-10153 development progresses

Oct. 4, 1996

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Interim phase II results reported for Neutralase

Oct. 4, 1996

Further patent coverage for vascular disease therapy

Oct. 4, 1996

New bi-ventricular pacemaker enters clinical trials

Oct. 4, 1996

HemoCleanse evaluates sorbent-based system in sepsis

Oct. 4, 1996

T Cell Sciences receives grant to develop CETP vaccine

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...